27.11.2014 Views

A Guide to Primary Care of People with HIV/AIDS - Canadian Public ...

A Guide to Primary Care of People with HIV/AIDS - Canadian Public ...

A Guide to Primary Care of People with HIV/AIDS - Canadian Public ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

A <strong>Guide</strong> <strong>to</strong> <strong>Primary</strong> <strong>Care</strong> <strong>of</strong> <strong>People</strong> <strong>with</strong> <strong>HIV</strong>/<strong>AIDS</strong><br />

Index <strong>of</strong> Topics<br />

his<strong>to</strong>ry<br />

fatigue questions, 58<br />

intitial contact, 14–15<br />

risk assessment, 23<br />

<strong>HIV</strong><br />

patient education, 15<br />

postexposure prophylaxis, 89–92<br />

risk fac<strong>to</strong>rs, 99<br />

and substance use, 106<br />

transmission case studies, 95–96<br />

transmission potential, 22<br />

vertical transmission prevention, 98–<br />

100<br />

<strong>HIV</strong> care characteristics, 135<br />

hope, 127<br />

hospice care, 126<br />

HSV. see herpes simplex virus (HSV)<br />

hyperemesis gravidarum, 101<br />

hyperglycemia, 45, 101<br />

hyperlactatemia, 44<br />

hypogonadism, 62<br />

hypoxemia, 68<br />

I<br />

immunization, 33<br />

immunologic failure, 31–32<br />

infants, 16, 101<br />

infections, 16<br />

insulin resistance<br />

and ART, 39<br />

moni<strong>to</strong>ring, 40<br />

protease inhibi<strong>to</strong>rs, 45<br />

treatment recommendations, 41<br />

intensification, 32<br />

interdisciplinary approach<br />

care model, 134–136<br />

patient benefits, 18<br />

practice integration, 155<br />

intermittent therapy, 34<br />

internet, 151–154<br />

intrauterine devices, 98<br />

intregrated model <strong>of</strong> care, 123–124<br />

J<br />

journals, 151–152<br />

K<br />

Kaposi sarcoma (KS), 68, 73–74<br />

L<br />

labora<strong>to</strong>ry tests<br />

abnormal values, 77–82<br />

HCV exposure, 92–93<br />

initial contact, 16–17<br />

pregnant women, 100<br />

for STDs, 23–24<br />

for substance abuse, 106<br />

lactic acidosis<br />

and ART, 39<br />

case studies, 48, 65<br />

drug cause, 55<br />

moni<strong>to</strong>ring, 40<br />

overview, 43–44<br />

during pregnancy, 101<br />

lipid abnormalities, 39–42<br />

lipodystrophy. see fat redistribution<br />

liver function tests, 79<br />

lymphoma, 72, 74<br />

M<br />

maintenance medications, 109<br />

malignancies<br />

and <strong>HIV</strong> infection, 68, 73–74<br />

psychiatric symp<strong>to</strong>ms, 115<br />

malnutrition, 61–62<br />

manic depressive illness, 117<br />

MCMD. see minor cognitive-mo<strong>to</strong>r<br />

disorder (MCMD)<br />

meningitis, 72<br />

mental health, 109, 115<br />

minor cognitive-mo<strong>to</strong>r disorder (MCMD),<br />

116<br />

minorities, 5<br />

mi<strong>to</strong>chondria, 44<br />

molluscum contagiosum, 60<br />

mood disorders, 117<br />

index<br />

U.S. Department <strong>of</strong> Health and Human Services, Health Resources and Services Administration, <strong>HIV</strong>/<strong>AIDS</strong> Bureau<br />

161

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!